UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines chronic kidney disease
Unstable angina / NSTEMI Microchapters |
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
Special Groups |
Diagnosis |
Laboratory Findings |
Treatment |
Antitplatelet Therapy |
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
Mechanical Reperfusion |
Discharge Care |
Case Studies |
UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines chronic kidney disease On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
ACC / AHA Guidelines for Chronic Kidney Disease[1] (DO NOT EDIT)
"1. Creatinine clearance should be estimated in UA/NSTEMI patients and the doses of renally cleared medications should be adjusted according to the pharmacokinetic data for specific medications. (Level B)" |
"2. Patients undergoing cardiac catheterization with receipt of contrast media should receive adequate preparatory hydration. (Level B)" |
"3. Calculation of the contrast volume to creatinine clearance ratio is useful to predict the maximum volume of contrast media that can be given without significantly increasing the risk of contrast-associated nephropathy. (Level B)" |
"1. An invasive strategy is reasonable in patients with mild (stage 2) and moderate (stage 3) CKD. (Level B) (There are insufficient data on benefit/risk of invasive strategy in UA/NSTEMI patients with advanced CKD [stages 4, 5].)" |
References
- ↑ 2012 Writing Committee Members. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR; et al. (2012). "2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 126 (7): 875–910. doi:10.1161/CIR.0b013e318256f1e0. PMID 22800849.